Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors

Clinical trial NCT00293124 · COMPLETED

Trial details

NCT number: NCT00293124
Sponsor: Central European Cooperative Oncology Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumors

Start date: 2004-03-01
Primary completion: 2006-07-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.